Within the Hernia Balloon market, application segmentation is anchored on the anatomical site of hernia repair. Inguinal hernias dominate the landscape, accounting for roughly 45 % of device deployments, driven by their high incidence and the clinical preference for minimally invasive reinforcement. Ventral hernias represent the second largest application at 30 %, reflecting expanding use in both elective and emergency settings where balloon-assisted tissue approximation mitigates recurrence risk. Umbilical hernias contribute about 15 % of the market, primarily in pediatric and young adult cohorts where device size and flexibility align with smaller defect dimensions. Incisional hernias, comprising the remaining 10 %, are characterized by complex scar tissue and variable defect geometry, prompting specialized balloon designs. Collectively, these application categories delineate the demand curve for Hernia Balloons, with each segment’s share directly influencing production volumes, pricing strategies, and R&D allocation. The proportional distribution underscores the relevance of a nuanced market taxonomy for stakeholders seeking to align product portfolios with clinical prevalence globally.